YAP1 and hepatocellular carcinoma: The expression of YAP/TAZ also functions as a prognostic marker, for instance, YAP/TAZ expression is associated with poor prognosis in hepatocellular carcinoma (HCC), cholangiocarcinoma patients, lung, and colorectal cancers [65,66,67,68].